electroCore, Inc. (ECOR) Earnings Call Transcripts
electroCore, Inc.'s Latest Earnings Call - June 23, 2026
ElectroCore, Inc. reported Q1 2026 revenue of $9.6 million, marking a 43% year-over-year increase. The company has guided for over 30% revenue growth for the full fiscal year 2026, aiming for approximately $42 million. The introduction of a new commercial leader, Mike Fox, is expected to enhance commercial adoption and potentially reduce sales and marketing expenses. ElectroCore's gross margin has improved significantly, reaching 87% in Q1 2026, up from 72% in 2019. The company is focusing on expanding its presence in the Veterans Administration (VA) and other federal markets, with a strategic emphasis on noninvasive, non-opioid therapeutic products.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $9.6 million (beat) |
| Gross Margin | 87% (beat) |
| Cash Balance | $8.8 million (neutral) |
| Full Year Revenue Guidance | $42 million (positive) |
Guidance from management
Management has guided for over 30% revenue growth in 2026, targeting approximately $42 million in revenue. They expect to reduce sales and marketing expenses as a percentage of revenue.
What analysts pressed on
Analysts questioned the sustainability of the 30% growth target and the potential for Quell to surpass gammaCore in the VA market. Concerns were also raised about the company's ability to penetrate the Department of Defense market and the scalability of the TruVega product line.
Main topics on the call
- Revenue Growth and Guidance — ElectroCore achieved a 43% revenue growth in Q1 2026 and has guided for over 30% growth for the full year. Management stated, 'we believe that, that 30% revenue growth is actually something that's very achievable.'
- Gross Margin Improvement — Gross margins have increased to 87% in Q1 2026 from 72% in 2019. Management guides for margins in the mid-80s range, indicating strong operational efficiency.
- VA Market Penetration — The VA remains a key revenue driver, but current penetration is only 2.5% of the 600,000 headache patients. Management sees 'tremendous upside' in this market.
- New Commercial Leadership — Mike Fox, the new Chief Operating Officer, is expected to drive revenue growth, particularly in federal markets. He has a track record of growing revenues from $20 million to $80 million in 18 months.
Read the full electroCore, Inc. transcript (June 23, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About electroCore, Inc.
electroCore, Inc. (ECOR) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 55 calls on record spanning March 23, 2020 to August 6, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 55 electroCore, Inc. earnings call transcripts on record, spanning March 23, 2020 to August 6, 2026. Based on this history, electroCore, Inc. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ECOR
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Calls on record
- 55
- First call
- March 23, 2020
- Most recent
- August 6, 2026
- Reporting cadence
- quarterly